Melissa M. Tomkiel
Director, Co-CEO and General Counsel · 7 filings · Latest: Sep 24, 2026
Strata Critical Medical, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
SRTA | Melissa M. Tomkiel | Director, Co-CEO and General Counsel | Jun 8, 2026 | Sale | $5.87 | 29,730 | $174.5K | 1,892,774 | |
SRTA | MELISSA TOMKIEL | — | Aug 4, 2025 | Proposed Sale | $3.78 | 47,995 | $181.4K | — | |
SRTA | MELISSA TOMKIEL | — | Jun 9, 2025 | Proposed Sale | $3.80 | 100,000 | $380.0K | — | |
SRTA | MELISSA TOMKIEL | — | Nov 29, 2024 | Proposed Sale | $4.39 | 44,621 | $195.9K | — | |
SRTA | MELISSA TOMKIEL | — | Nov 27, 2024 | Proposed Sale | $3.96 | 89,242 | $353.4K | — | |
SRTA | MELISSA TOMKIEL | — | Nov 12, 2024 | Proposed Sale | $3.83 | 44,621 | $170.9K | — |